The launch of Sovaldi, the $1,000-a-day pill for hepatitis C, is shaping up as the most successful ever.
The Food and Drug Administration approved the pill in December. And then Gilead Sciences was off to the races. The company said it sold $2.27 billion worth of Sovaldi in the quarter that ended March 31. $2.27 billion!
The big names in the growing education-technology industry gathered in Arizona this week.
The "Education Innovation Summit" styles itself the "Davos of ed-tech." Educators, philanthropists and political leaders like Jeb Bush rubbed elbows with the investors, venture capitalists, big companies like Microsoft and small companies hoping to get big. It's hosted by Arizona State University and GSV, a private equity firm.
Originally published on Thu April 24, 2014 6:24 am
Maybe you turn up your music when your neighbor complains about the noise.
Or maybe you curse a baby princess because you didn't get invited to her christening, as in "Sleeping Beauty" and its latest incarnation, the upcoming movie "Maleficent."
To see spite in its purest form, try brunch in New York. At the hippest restaurants, patrons will linger at their tables long after they've paid the bill, just to show those losers on the wait list who's boss – even though they're wasting their own time in the process.